Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review.

The global burden of diabetes mellitus (DM) is immense, with numbers expected to rise to over 550 million by 2030. Countries in Asia, such as India and China, will bear the brunt of this unfolding epidemic. Persons with DM have a significantly increased risk of developing active tuberculosis (TB) that is two to three times higher than in persons without DM. This article reviews the epidemiology and interactions of these two diseases, discusses how the World Health Organization and International Union Against Tuberculosis and Lung Disease developed and launched the Collaborative Framework for the care and control of TB and DM, and examines three important challenges for care. These relate to 1) bi-directional screening of the two diseases, 2) treatment of patients with dual disease, and 3) prevention of TB in persons with DM. For each area, the gaps in knowledge and the priority research areas are highlighted. Undiagnosed, inadequately treated and poorly controlled DM appears to be a much greater threat to TB prevention and control than previously realised, and the problem needs to be addressed. Prevention of DM through attention to unhealthy diets, sedentary lifestyles and childhood and adult obesity must be included in broad non-communicable disease prevention strategies. This collaborative framework provides a template for action, and the recommendations now need to be implemented and evaluated in the field to lay down a firm foundation for the scaling up of interventions that work and are effective in tackling this dual burden of disease.

[1]  A. Harries,et al.  The double burden of diabetes and tuberculosis - public health implications. , 2013, Diabetes research and clinical practice.

[2]  M. Jiménez-Corona,et al.  Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes , 2012, Thorax.

[3]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[4]  A. Harries,et al.  Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan , 2012, Tropical medicine & international health : TM & IH.

[5]  A. Harries,et al.  High Diabetes Prevalence among Tuberculosis Cases in Kerala, India , 2012, PloS one.

[6]  K. Polonsky,et al.  The past 200 years in diabetes. , 2012, The New England journal of medicine.

[7]  A. Harries,et al.  Screening patients with Diabetes Mellitus for Tuberculosis in China , 2012, Tropical medicine & international health : TM & IH.

[8]  V. Viswanathan,et al.  Prevalence of Diabetes and Pre-Diabetes and Associated Risk Factors among Tuberculosis Patients in India , 2012, PloS one.

[9]  Y. Ben Amor,et al.  The Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing World , 2012, PLoS medicine.

[10]  A. Harries,et al.  The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  C. Pipper,et al.  Diabetes Is a Risk Factor for Pulmonary Tuberculosis: A Case-Control Study from Mwanza, Tanzania , 2011, PloS one.

[12]  Soham Gupta,et al.  Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India. , 2011, Journal of infection and public health.

[13]  Gretchen A. Stevens,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[14]  A. Harries,et al.  The impact of diabetes on tuberculosis treatment outcomes: A systematic review , 2011, BMC medicine.

[15]  G. Roglić,et al.  Nutrition, Diabetes and Tuberculosis in the Epidemiological Transition , 2011, PloS one.

[16]  M. Rahbar,et al.  Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. , 2011, Bulletin of the World Health Organization.

[17]  R. Chaisson,et al.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  T. Cohen,et al.  Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. , 2011, International journal of epidemiology.

[19]  A. Harries,et al.  Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  A. Harries,et al.  Bi‐directional screening for tuberculosis and diabetes: a systematic review , 2010, Tropical medicine & international health : TM & IH.

[21]  B. Alisjahbana,et al.  Implications of the global increase of diabetes for tuberculosis control and patient care , 2010, Tropical medicine & international health : TM & IH.

[22]  G. Roglić,et al.  Defining the research agenda to reduce the joint burden of disease from Diabetes mellitus and Tuberculosis , 2010, Tropical medicine & international health : TM & IH.

[23]  K. Floyd,et al.  Tuberculosis control and elimination 2010–50: cure, care, and social development , 2010, The Lancet.

[24]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[25]  C. Snehalatha,et al.  Diabetes in Asia , 2010, The Lancet.

[26]  K. Dooley,et al.  Tuberculosis and diabetes mellitus: convergence of two epidemics. , 2009, The Lancet. Infectious diseases.

[27]  M. Murray,et al.  Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational Studies , 2008, PLoS medicine.

[28]  G. Leung,et al.  Diabetic control and risk of tuberculosis: a cohort study. , 2008, American journal of epidemiology.

[29]  A. Jahn,et al.  Adapting the DOTS Framework for Tuberculosis Control to the Management of Non-Communicable Diseases in Sub-Saharan Africa , 2008, PLoS medicine.

[30]  G. Roglić,et al.  Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence , 2007, BMC Public Health.

[31]  G. Roglić,et al.  Diabetes and the risk of tuberculosis: a neglected threat to public health? , 2007, Chronic illness.

[32]  R. Erasmus,et al.  The significance of glucose intolerance in pulmonary tuberculosis. , 1990, Tubercle.

[33]  K. Mathur,et al.  Manifest, chemical and latent chemical diabetes in pulmonary tuberculosis. , 1973, The Journal of the Association of Physicians of India.

[34]  Lesnichiĭ Av,et al.  Experience with the chemoprophylaxis of pulmonary tuberculosis in diabetes mellitus patients , 1969 .

[35]  R. Pfaffenberg,et al.  [Isoniazid & recurrence of tuberculosis in diabetics]. , 1958, Zeitschrift fur Tuberkulose.